生物活性 | |||
---|---|---|---|
描述 | ZED-1227 is a targeted and orally bioavailable inhibitor of transglutaminase 2 (TG2) with an IC50 of 45 nM. It is effective in blocking inflammation-driven TG2 expression and activity, making it a candidate for celiac disease (CeD) research[1].[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.89mL 0.38mL 0.19mL |
9.46mL 1.89mL 0.95mL |
18.92mL 3.78mL 1.89mL |
参考文献 |
---|